It is known as a specific therapy since it specifically targets the CD38  which happen to be above expressed around the multiple myeloma cells. Darzalex is from a class of medicines termed CD38 monoclonal antibodies. Darzalex will not be a chemotherapy.These are biological solutions that have now been approved via the FDA, versus which biosimilar